|
|
News Breaks | | | | December 4, 2012 | | 13:29 EDT |  | TEVA, GALE | Galena Biopharma to partner with Teva in Israel
Galena Biopharma (GALE), a biotechnology company focused on oncology treatments, announced earlier today that it has signed an agreement with a subsidiary of Teva Pharmaceutical Industries for the commercialization of NeuVax, a breast cancer treatment, in Israel. Under the agreement, Teva Israel will assume responsibility for regulatory registration in Israel, provide financial support for local development, and will commercialize the product in the region. Specific financial terms were not disclosed, but the agreement allows for significant royalty payments to Galena Biopharma on future sales. | |
|
News For TEVA;GALE From The Last 14 Days Check below for free stories on TEVA;GALE the last two weeks. |
|
|
| May 24, 2013 | | 16:14 EDT |  | GALE | Galena Biopharma files $150M mixed securities shelf
| | | May 22, 2013 | | 16:23 EDT | | TEVA | Alexza Pharmaceuticals chief commercial officer to leave company
 Subscribe for More Information | | | 07:58 EDT |  | GALE | Galena Biopharma initiated with an Outperform at JMP Securities
Subscribe for More Information | | | 06:20 EDT | | GALE | Galena Biopharma initiated with an Outperform at JMP Securities
| | | May 20, 2013 | | 11:27 EDT | | TEVA | Appeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva
Subscribe for More Information | | | May 13, 2013 | | 09:44 EDT |  | TEVA | Several companies reportedly interested in buying Adcock Ingram, Globes says
Subscribe for More Information | | | 07:49 EDT |  | TEVA | FDA decision on Opana a modest positive for Impax, says Leerink
Leerink views the FDA's denial of Endo's (ENDP) Citizen Petition as a modest positive for Impax (IPXL), which it notes is the sole holder of 180 day exclusivity on generic Opana. However, Leerink says upside for Impax will be limited as Actavis (ACT), Sandoz, and Teva (TEVA) have settlements to enter the market starting in June 2013 when Impax's 180-day generic exclusivity expires. | |
|
|
|
|
|
|
